Emerging Therapeutic Interventions for Idiopathic Pulmonary Fibrosis|
Idiopathic pulmonary fibrosis is a devastating and relentlessly progressive lung disorder. The authors discuss existing therapies and highlight some of the recent, novel therapeutics being explored in the current clinical landscape for the treatment of this chronic, disabling disorder. They also discuss the pathogenic rationale behind current therapies. [Expert Opin Investig Drugs]
Visit our reviews page to see a complete list of reviews in the pulmonary cell research field.
Have we missed an important article or publication in Pulmonary Cell News? Click here to submit!
Comments or Suggestions? Submit your feedback here.